article · Journal of Liposome Research

PEGylated flexosomes as a novel intranasal carrier for quetiapine: formulation, characterization, and <i>in vivo</i> studies

2026Misr University for Science and Technology

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

. Histopathological evaluation confirmed the formulation's safety. PFs present a promising platform for enhanced intranasal QTP delivery.

Research topics

Advanced Drug Delivery Systems
Lipid Membrane Structure and Behavior
Advancements in Transdermal Drug Delivery

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1080/08982104.2026.2619917

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.